Tuesday, Nov. 13, 2018 NIAID Scientists Illuminate Causes of Hepatitis B Virus-Associated Acute Liver Failure NIAID scientists and their Italian collaborators have found that hepatitis B virus (HBV)-associated acute liver failure (ALF) results from an uncommon encounter between a highly mutated HBV variant and an unusual immune response in the patient's liver. HBV-ALF is a rare condition that can turn fatal within days without liver transplantation. The researchers made the discoveries by examining liver samples taken from four patients who developed HBV-ALF, one of the most dramatic clinical syndromes in medicine, according to the research team. They hope their work provides a model of how the disease develops and will lead to new diagnostic, treatment and prevention strategies. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107